Literature DB >> 11145033

A reappraisal of HAQ disability in rheumatoid arthritis.

F Wolfe1.   

Abstract

OBJECTIVE: To investigate the course of self-reported disability in rheumatoid arthritis (RA) using the major self-report measure of functional impairment, the Health Assessment Questionnaire (HAQ).
METHODS: The course of HAQ disability was assessed in 32,525 observations (1,843 patients) in which the HAQ was administered. In addition, a subset of 2,189 visits from 50 patients, followed on average for 17 years, was studied to model the effect of disease duration on the course of HAQ disability in individual patients. Linear and fractional polynomial regression as well as smoothing algorithms were applied to the group of RA patients and then to the individual course of patients.
RESULTS: Group linear and nonlinear models of the effect of disease duration on HAQ disability were found to have 3 characteristics: 1) HAQ disability scores are high at disease onset rather than gradually increasing; 2) HAQ disability increases very slowly over time (0.03 units per year); and 3) all such models fit very poorly, explaining only 5% of the variance in HAQ disability scores. However, application of nonlinear models to individual patient courses (as opposed to groups of patients) explains 37% of the HAQ disability score variation. In some patients, the course of HAQ disability was either 1) chaotic (scores change without any pattern) or 2) determinable, but unrelated to time. When covariates were added to the group model, however, the course of HAQ disability became clearer, and 51% of the variance in the disability score could be explained, statistically, by pain, depression, erythrocyte sedimentation rate, and disease duration.
CONCLUSION: Individual RA patients have differing, characterizable courses: 1) nonlinear, 2) chaotic, or 3) non-time determined. The model that self-reported physical disability, as measured by the HAQ, occurs as a function of disease acting over time does not fit the data well and is an inadequate model. This discrepancy may also be the result of the patient's upward reappraisal of functional ability with increasing time. The predominant determinants of HAQ disability in RA are disease activity, pain, and psychosocial factors rather than structural abnormality. Although the HAQ is a useful clinical tool and a central measure of disease outcome, it measures both process and outcome, and usually more process than outcome. Individual patient models that include all that is known about the patient--the paradigm of clinical care-may be a more effective way to examine the course of RA than are conventional group-based models.

Entities:  

Mesh:

Year:  2000        PMID: 11145033     DOI: 10.1002/1529-0131(200012)43:12<2751::AID-ANR15>3.0.CO;2-6

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  51 in total

1.  Newly diagnosed rheumatoid arthritis.

Authors:  M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-04       Impact factor: 19.103

Review 2.  Benchmarking and the percentile assessment of RA: adding a new dimension to rheumatic disease measurement.

Authors:  F Wolfe; H K Choi
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

3.  Follow up studies in rheumatoid arthritis.

Authors:  R Landewé; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

4.  The challenge of following process, damage, and function in patients with rheumatoid arthritis in clinical care.

Authors:  Josef S Smolen; Daniel Aletaha
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

5.  Patients with rheumatoid arthritis in clinical care.

Authors:  J S Smolen; D Aletaha
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

Review 6.  Predictive factors of work disability in rheumatoid arthritis: a systematic literature review.

Authors:  E M de Croon; J K Sluiter; T F Nijssen; B A C Dijkmans; G J Lankhorst; M H W Frings-Dresen
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

7.  Health status in rheumatoid arthritis over 7 years.

Authors:  A Boonen; R Landewé
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

8.  Reliability of the ICF Core Set for rheumatoid arthritis.

Authors:  Till Uhlig; Solvår Lillemo; Rikke Helene Moe; Tanja Stamm; Alarcos Cieza; Annelies Boonen; Petter Mowinckel; Tore Kristian Kvien; Gerold Stucki
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

9.  The cost effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UK.

Authors:  Marco Barbieri; John B Wong; Michael Drummond
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

10.  Anxiety and depression in rheumatoid arthritis: an epidemiologic survey and investigation of clinical correlates in Iranian population.

Authors:  Ahmad-Reza Jamshidi; Arash Tehrani Banihashemi; Pedram Paragomi; Maryam Hasanzadeh; Mozhgan Barghamdi; Shima Ghoroghi
Journal:  Rheumatol Int       Date:  2016-05-18       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.